Exopharm Ltd
ASX:EX1
Exopharm Ltd
ASX:EX1
Price:
0.023
AUD
Market Closed
Market Cap:
AU$1.6m
Cash Flow Statement
Cash Flow Statement
Exopharm Ltd
Exopharm Ltd
Currency: AUD
| Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Cash Interest Paid |
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
1
|
3
|
2
|
4
|
4
|
4
|
4
|
3
|
|
| Cash from Operating Activities |
(7)
N/A
|
(6)
+12%
|
(8)
-33%
|
(7)
+4%
|
(9)
-14%
|
(7)
+18%
|
(4)
+45%
|
(1)
+66%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Other Items |
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
1
|
|
| Cash from Investing Activities |
(1)
N/A
|
(2)
-74%
|
(2)
-9%
|
(2)
+14%
|
(1)
+20%
|
(1)
+47%
|
(0)
+58%
|
1
N/A
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
5
|
10
|
22
|
12
|
0
|
0
|
2
|
0
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(1)
|
2
|
0
|
(0)
|
0
|
|
| Other |
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
5
N/A
|
10
+92%
|
21
+116%
|
11
-49%
|
2
-82%
|
(0)
N/A
|
1
N/A
|
2
+79%
|
|
| Change in Cash | |||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Net Change in Cash |
(3)
N/A
|
2
N/A
|
11
+456%
|
2
-86%
|
(8)
N/A
|
(8)
+2%
|
(3)
+58%
|
1
N/A
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(7)
N/A
|
(7)
+1%
|
(9)
-31%
|
(9)
+8%
|
(10)
-11%
|
(8)
+21%
|
(4)
+46%
|
(1)
+65%
|
|
Switch to:
Switch to:
See Also
Discover More
